LIXTE BIOTECHNOLOGY HOLDINGS, INC. (22)
Browse by Contract Category
Contracts
-
Securities Purchase Agreement
(Filed With SEC on April 15, 2022)
-
Sales Agreement dated as of September 20, 2021 between Lixte Biotechnology Holdings, Inc. and WestPark Capital, Inc
(Filed With SEC on September 20, 2021)
-
Amendment to Employment Agreement between the Company and Eric Forman
(Filed With SEC on March 26, 2021)
-
Form of Underwriter Agreement
(Filed With SEC on November 16, 2020)
-
Form of Placement Agents Warrant
(Filed With SEC on April 15, 2022)
-
Development Collaboration Agreement by and between Lixte Biotechnology Holdings, Inc. and the Netherlands Cancer Institute, Amsterdam, and Oncode Institute, Utrecht, entered into...
(Filed With SEC on November 10, 2021)
-
Securities Purchase Agreement
(Filed With SEC on March 2, 2021)
-
Form of Placement Agents Warrant
(Filed With SEC on March 2, 2021)
-
Underwriting Agreement, dated as of November 25, 2020, between the Company and WestPark Capital, Inc. and WallachBeth, LLC
(Filed With SEC on November 27, 2020)
-
Form of Public Warrant
(Filed With SEC on November 27, 2020)
-
Warrant Agency Agreement, dated as of November 25, 2020, between the Company and Computershare
(Filed With SEC on November 27, 2020)
-
Form of Warrant Agent Agreement
(Filed With SEC on November 16, 2020)
-
Form of Warrant included in Unit
(Filed With SEC on November 16, 2020)
-
Form of Underwriter Agreement
(Filed With SEC on October 13, 2020)
-
Employment Agreement with Robert Weingarten
(Filed With SEC on August 18, 2020)
-
Master Service Agreement with Foundation of Angelman Syndrome Therapeutics FAST
(Filed With SEC on August 18, 2020)
-
Employment Agreement with Dr. James Miser
(Filed With SEC on July 17, 2020)
-
Employment Agreement with Eric Forman
(Filed With SEC on July 17, 2020)
-
Employment Agreement with Dr. John Kovach
(Filed With SEC on July 17, 2020)
-
Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan
(Filed With SEC on July 17, 2020)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 25, 2020)
-
Clinical Trial Research Agreement1
(Filed With SEC on August 6, 2019)